Clinical Trial Update: A Long-Term Follow-Up Study in Subjects Who Received vMCO-I Administered Via Intravitreal Injection

View source ↗

Summary

A long-term follow-up study update of subjects who received intravitreal vMCO-I, focusing on durability and safety of the therapy over time.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinal Degeneration
• Retinitis Pigmentosa

Drugs mentioned

• vMCO-I

Snippet

Sponsor: Nanoscope Therapeutics Inc. | Conditions: Retinitis Pigmentosa, Retinal Disease | Status: ENROLLING_BY_INVITATION